Improved survival for elderly married glioblastoma patients: Better treatment delivery, less toxicity, and fewer disease complications;Verbessertes Überleben für verheiratete ältere Glioblastompatienten: Bessere Therapiedurchführbarkeit, geringere Toxizität und weniger Erkrankungskomplikationen

Strahlentherapie und Onkologie

Volumn 192, Issue 11, 2016, Pages 797-805

  Putz, Florian ^a   Putz, Tobias ^b   Goerig, Nicole ^a   Knippen, Stefan ^a   Gryc, Thomas ^a   Eyüpoglu, Ilker ^a   Rössler, Karl ^a   Semrau, Sabine ^a   Lettmaier, Sebastian ^a   Fietkau, Rainer ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF BAMBERG   (Germany)

Author keywords

Elderly; Glioblastoma; Marital status; Radiotherapy; Temozolomide

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; TEMOZOLOMIDE;

AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; GLIOBLASTOMA; HUMAN; INFECTION; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LIVER TOXICITY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL RECORD REVIEW; NEUROLOGICAL COMPLICATION; OVERALL SURVIVAL; RADIATION INJURY; THROMBOCYTOPENIA; ADULT; BRAIN INJURY; BRAIN NEOPLASMS; CAUSALITY; COMPARATIVE STUDY; EPIDEMIOLOGY; GERMANY; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; MORTALITY; PSYCHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SPOUSE; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN INJURIES; BRAIN NEOPLASMS; CAUSALITY; FEMALE; GERMANY; GLIOBLASTOMA; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MARITAL STATUS; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDIES; RISK FACTORS; SPOUSES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84987623326     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-016-1046-0     Document Type: Article

References (33)

1. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2007–2011. Neuro-oncology 16(suppl 4):iv1–iv63. doi:10.1093/neuonc/nou223
2. Stupp R, Mason WP, Bent MJ van den, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330
3. Simo M, Velasco R, Graus F, Verger E, Gil M, Pineda E, Blasco J, Bruna J (2012) Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy. J Neurooncol 108(3):451–458. doi:10.1007/s11060-012-0836-1
4. Jen JF, Cutler DL, Pai SM, Batra VK, Affrime MB, Zambas DN, Heft S, Hajian G (2000) Population pharmacokinetics of temozolomide in cancer patients. Pharm Res 17(10):1284–1289
5. Laperriere N, Weller M, Stupp R, Perry JR, Brandes AA, Wick W, Bent MJ van den (2013) Optimal management of elderly patients with glioblastoma. Cancer Treat Rev 39(4):350–357. doi:10.1016/j.ctrv.2012.05.008
6. Sijben AE, McIntyre JB, Roldan GB, Easaw JC, Yan E, Forsyth PA, Parney IF, Magliocco AM, Bernsen H, Cairncross JG (2008) Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 89(1):97–103. doi:10.1007/s11060-008-9593-6
7. Bauchet L, Zouaoui S, Darlix A, Menjot de Champfleur N, Ferreira E, Fabbro M, Kerr C, Taillandier L (2014) Assessment and treatment relevance in elderly glioblastoma patients. Neuro-oncology 16(11):1459–1468. doi:10.1093/neuonc/nou063
8. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85(9):704–710. doi:10.1093/jnci/85.9.704
9. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7):707–715. doi:10.1016/s1470-2045(12)70164-x
10. Hegi ME, Diserens A‑C, Gorlia T, Hamou M‑F, Tribolet N de, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JEC, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997–1003. doi:10.1056/NEJMoa043331
11. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62(3):564–576. doi:10.1227/01.neu.0000317304.31579.17
12. Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, Prados MD (2006) Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro-oncology 8(1):12–26. doi:10.1215/s1522851705000268
13. Mukherjee D, Sarmiento JM, Nosova K, Boakye M, Lad SP, Black KL, Nuno M, Patil CG (2014) Effectiveness of radiotherapy for elderly patients with anaplastic gliomas. J Clin Neurosci 21(5):773–778. doi:10.1016/j.jocn.2013.09.004
14. Chang SM, Barker FG 2nd (2005) Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer 104(9):1975–1984. doi:10.1002/cncr.21399
15. Wachtel MS, Yang S (2014) Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era. Cancer Med 3(3):660–666. doi:10.1002/cam4.213
16. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64(6):628–634. doi:10.1002/ana.21521
17. Nuno M, Birch K, Mukherjee D, Sarmiento JM, Black KL, Patil CG (2013) Survival and prognostic factors of anaplastic gliomas. Neurosurgery 73(3):458–465. doi:10.1227/01.neu.0000431477.02408.5e
18. Aizer AA, Chen MH, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE, Hu JC, Nguyen PL (2013) Marital status and survival in patients with cancer. J Clin Oncol 31(31):3869–3876. doi:10.1200/jco.2013.49.6489
19. Aneja S, Khullar D, Yu JB (2013) The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme. J Neurooncol 112(3):393–401. doi:10.1007/s11060-013-1068-8
20. Walker GV, Li J, Mahajan A, McAleer MF, Groot JF de, Azeem SS, Brown PD (2012) Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme: a population-based analysis. Cancer 118(18):4538–4544. doi:10.1002/cncr.27439
21. Yabroff KR, Harlan L, Zeruto C, Abrams J, Mann B (2012) Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro-oncology 14(3):351–359. doi:10.1093/neuonc/nor218
22. Dorr W, Herrmann T, Baumann M (2014) Application of organ tolerance dose-constraints in clinical studies in radiation oncology. Strahlenther Onkol 190(7):621–624, 626–627. doi:10.1007/s00066-014-0613-5
23. Chinnaiyan P, Won M, Wen PY, Rojiani AM, Wendland M, Dipetrillo TA, Corn BW, Mehta MP (2013) RTOG 0913: a phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 86(5):880–884. doi:10.1016/j.ijrobp.2013.04.036
24. Becker F, Hecht M, Schmidtner J, Semrau S, Fietkau R (2014) Temozolomide-induced liver damage. A case report. Strahlenther Onkol 190(4):408–410. doi:10.1007/s00066-013-0519-7
25. Sarganas G, Orzechowski HD, Klimpel A, Thomae M, Kauffmann W, Herbst H, Bronder E, Garbe E (2012) Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. Neuro-oncology 14(5):541–546. doi:10.1093/neuonc/nos056
26. Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rube C (2011) Toxicity after radiochemotherapy for glioblastoma using temozolomide – a retrospective evaluation. Radiat Oncol 6:141. doi:10.1186/1748-717x-6-141
27. Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA (2009) Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 27(7):1082–1086. doi:10.1200/jco.2008.19.1098
28. Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H (2014) Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme. Strahlenther Onkol 190(10):933–938. doi:10.1007/s00066-014-0696-z
29. Verbrugge LM (1979) Marital status and health. J Marriage Fam 41(2):267–285. doi:10.2307/351696
30. Lipowicz A, Lopuszanska M (2005) Marital differences in blood pressure and the risk of hypertension among Polish men. Eur J Epidemiol 20(5):421–427. doi:10.1007/s10654-005-1752-x
31. Hoebel J, Starker A, Jordan S, Richter M, Lampert T (2014) Determinants of health check attendance in adults: findings from the cross-sectional German Health Update (GEDA) study. BMC Public Health 14:913. doi:10.1186/1471-2458-14-913
32. Eng PM, Kawachi I, Fitzmaurice G, Rimm EB (2005) Effects of marital transitions on changes in dietary and other health behaviours in US male health professionals. J Epidemiol Community Health 59(1):56–62. doi:10.1136/jech.2004.020073
33. Joung IM, Mheen H, Stronks K, Poppel FW van, Mackenbach JP (1994) Differences in self-reported morbidity by marital status and by living arrangement. Int J Epidemiol 23(1):91–97